Under the topline numbers, congressional appropriators are looking for more information on federal workforce numbers, contracts, telework agreements and more.
Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback